There's a lot of nonsense here both from loyal shareholders and shorters. I feel for the shareholders. It could come good again if the products does come through with positive results. I am just an observer on the sidelines so no hold or sentiment. Like the science but there's a way to go being Phase 1 for most products in IMU's lineup. (just look at PAR Paradigm with Phase 3 launch and yet SP is at all time low, science says also works. Biopharma companies require alot of monies to fund trials even product looks good). I believe IMU next announcement will be R&D rebate of approx $11m. However, I do believe $11.8m is also owed to Precision once they initiate Azer cell Phase 2 registrational studies sometime next year, so guess it negates this inflow.
IMU Price at posting:
4.2¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)